At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 24, 2026 at 17:02 ET
Axsome Therapeutics is holding its 2026 annual meeting for shareholders to vote on director elections, auditor ratification, and executive compensation. This is a routine annual governance filing with no material financial or strategic changes disclosed.
- Annual shareholder meeting scheduled for June 5, 2026
- Voting on election of two directors: Mark Saad and Susan Mahony
- Ratification of Deloitte & Touche LLP as independent auditor
- Advisory vote on executive compensation
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access